ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988

In Brief: GM Prizes: Einhorn, McMahon, Nusslein-Volhard; James, Poznanski Lead Roentgen Ray Society

June 26, 1992

Rogers Reaffirms Congress’ Interest In Cancer Program; Act Renewal To “Broaden, Sustain It”

April 14, 1978

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011